Aishwarya Anand, Naveen C Hegde, Pulkit Chhabra, Jai Purohit, Rupesh Kumar, Ankur Gupta, Deepesh P Lad, Ritin Mohindra, Saurabh Mehrotra, Rajesh Vijayvergiya, Basant Kumar, Vishal Sharma, Pankaj Malhotra, Jasmina Ahluwalia, Reena Das, Amol N Patil, Nusrat Shafiq, Samir Malhotra
BACKGROUND: Empirical use of pharmacogenetic test(PGT) is advocated for many drugs, and resource-rich setting hospitals are using the same commonly. The clinical translation of pharmacogenetic tests in terms of cost and clinical utility is yet to be examined in hospitals of low middle income countries (LMICs). AIM: The present study assessed the clinical utility of PGT by comparing the pharmacogenetically(PGT) guided- versus standard of care(SOC)- warfarin therapy, including the health economics of the two warfarin therapies...
April 18, 2024: Annals of Hematology